Role of Contrast Enhanced Spectral Mammography to Predict Upgrade Rates of Biopsy Proven Atypical Ductal Hyperplasia

NCT03505372 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Unable to recruit to study due to limited number of patients with ADH

Conditions

Atypical Ductal Hyperplasia

Interventions

DEVICE: Contrast enhanced mammography

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]